US Patent Issued to Regeneron Pharmaceuticals on July 28 for "Maytansinoid derivatives, conjugates thereof, and methods of use" (Pennsylvania, New York Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,182, issued on July 28, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Maytansinoid derivatives, conjugates thereof, and methods of use" was invented by Thomas Nittoli (Pearl River, N.Y.) and Thomas P. Markotan (Newtown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are maytansinoid compounds, derivatives thereof, conjugates thereof, and methods of treating or preventing proliferative diseases with the same."

The patent was filed on Aug. 16, 2022, under Application No. 17/889,301.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO...